GlassScriptPhysician profile
Jane F Serio
NPI 1730185679
$5,228.73
in general payments reported to CMS, 2019-2025
40 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.23 · 2021: $565 · 2022: $362 · 2023: $958 · 2024: $1,431 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,212.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $917.15 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $671.08 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $613.93 | 2021-2025 | Ubrelvy, Qulipta, Linzess |
| Novartis Pharmaceuticals Corporation | $345.46 | 2021-2024 | |
| Glaxosmithkline, LLC. | $328.53 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $296.11 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $190.87 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.08 | 2021-2025 | Jardiance |
| Daiichi Sankyo INC. | $176.52 | 2023-2024 | Injectafer, Vanflyta |
| Idorsia Pharmaceuticals US INC | $141.88 | 2022-2024 | Quviviq |
| Mallinckrodt Hospital Products INC. | $124.64 | 2025 | Acthar |
| Exact Sciences Corporation | $121.96 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $117.38 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Amgen INC. | $114.54 | 2022-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $102.00 | 2023-2025 | Veozah |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Serio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.